The Airline Pilots’ Association of India issued an advisory warning that initial non-negative drug screenings can be triggered by common over-the-counter medicines [1].
The advisory follows a turbulence incident on an Air India flight traveling from Phuket, Thailand, to Delhi [2]. The association said airlines and pilots should exercise caution before taking disciplinary action based on preliminary tests, as these results may not accurately reflect substance abuse.
According to the association, a non-negative screening result is a preliminary flag pending confirmatory laboratory testing and review [1]. The group said certain medications available without a prescription can cause these false positives, which may lead to unfair accusations against flight crews.
Because of this risk, the APAI said pilots should treat any non-negative result as provisional until confirmatory testing is completed [2]. The association is seeking confidentiality for pilots during these processes to protect professional reputations while laboratory results are pending.
This warning emphasizes the technical gap between a rapid screening test and a formal laboratory confirmation. The association is advocating for a standardized approach to drug testing that accounts for medical variables, ensuring that no pilot is penalized based on a preliminary flag alone.
“A non‑negative screening result is a preliminary flag pending confirmatory laboratory testing and review.”
This move by the APAI highlights a tension between strict aviation safety protocols and the clinical limitations of rapid drug testing. By flagging the risk of false positives, the association is attempting to establish a procedural safeguard that prevents pilots from facing immediate professional repercussions before a gold-standard laboratory test can verify the presence of prohibited substances.
